EN
HI
Marksans Pharma share price chart
Marksans Pharma Share Key Metrics
Volume
45.52 L
Market Cap
12569.69 CR
LTQ@LTP
6@277.30
ATP
276.15
Var Margin
21.66 %
Circuit Range
210.8-316.1
Delivery %
38.45 %
Value
125.70 CR
ASM/GSM
No
Market Lot
1
Summary
MARKSANS stock price is ₹277.3 as of 9 Jul, 2026. The stock intraday movement has stayed between ₹263.50 and ₹281.60, while Marksans Pharma share price 52 week high low is ₹155.00 & ₹281.60.
In terms of trading activity, MARKSANS share price has recorded a volume of 45,51,970 shares. The Marksans Pharma has a market cap of ₹453288438. The stock’s Average Traded Price (ATP) stands at ₹276.15, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 6 @ ₹277.30.
The Marksans Pharma upper circuit limit is ₹316.10 & The Marksans Pharma lower circuit limit is ₹210.80, with a Value of ₹125.70 CR. The Delivery Percentage for the day is 38.45%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Marksans Pharma Fundamentals
P/E Ratio
28.57
P/B Ratio
3.95
Div. Yield
0.34
Sector P/E
68.55
Sector P/B
3.18
Sec. Div. Yield
0.53
Marksans Pharma Resistance and Support
Pivot 265.05
Resistance
First Resistance
271.1
Second Resistance
278.75
Third Resistance
284.8
Support
First Support
257.4
Second Support
251.35
Third Support
243.7
Marksans Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-26 | Audited Results & Final Dividend |
| 2026-02-05 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-19 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results |
Marksans Pharma News
Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Marksans Pharma acquired 100% of ABCnow GmbH, a Germany-based pharmaceutical company, for €892,384. This strategic move aims to expand Marksans' presence in regulated European markets and strengthen its forward integration.
Jul 08 2026 10:07:34
Marksans Pharma Ltd - 524404 - The Board Fixed 20 August 2026 As The Record Date For Ascertaining The Members Of The Company For Payment Of Dividend.
Marksans Pharma fixed August 20, 2026, as the Record Date for its ₹0.90 per equity share final dividend for FY26. Payment is scheduled on or after September 10, 2026.
Jul 03 2026 12:23:23
Read More
Marksans Pharma Management
| Name | Position |
|---|---|
| Harshavardhan Panigrahi | Company Secretary & Compliance Officer |
| Mark Saldanha | Chairman & Managing Director |
Marksans Pharma Similar Stocks
Concord Biotech Ltd.
1305.40
45.60 (3.62%)
Alivus Life Sciences Ltd.
1142.90
12.80 (1.13%)
Park Medi World Ltd.
290.15
16.25 (5.93%)
Viyash Scientific Ltd.
281.05
10.45 (3.86%)
CORONA Remedies Ltd.
2022.80
43.40 (2.19%)
Shilpa Medicare Ltd.
622.30
26.95 (4.53%)
Metropolis Healthcare Ltd.
560.05
10.70 (1.95%)
Sanofi Consumer Healthcare India Ltd.
4506.40
-32.90 (0.72%)
Strides Pharma Science Ltd.
1076.00
-4.80 (0.44%)
Akums Drugs & Pharmaceuticals Ltd.
658.20
10.85 (1.68%)
Marksans Pharma FAQs
The Buying Price of Marksans Pharma share is 277.3 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Marksans Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Marksans Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Marksans Pharma shares is 28.57. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Marksans Pharma shares is 3.95. Useful to assess the stock's value relative to its book value.
To assess Marksans Pharma’s valuation compare Sector P/E, P/B which are 68.55 & 3.18 with sector averages, along with growth rates and financial metrics.
The Market Cap of Marksans Pharma is 12569.69 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Marksans Pharma share price is 281.60 & 155.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Marksans Pharma belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
